Clinical Trials Logo

Bowel Necrosis clinical trials

View clinical trials related to Bowel Necrosis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01788904 Recruiting - Clinical trials for Acute Mesenteric Ischemia

Plasma i-FABP as Predictor for Irreversible Bowel Ischemia

FARAMIS
Start date: February 2013
Phase: N/A
Study type: Observational

In the FARAMIS study, we aim to investigate the longitudinal course of intestinal plasma fatty acid binding protein (i-FABP) in patients with acute mesenteric ischemia (AMI) undergoing primary percutaneous angiographic intervention. The investigators postulate that patients with fully re-established intestinal blood flow and vital intestines will display a significant drop of plasmatic i-FABP within 24 hours, while patients requiring subsequent intestinal resection due to irreversible bowel necrosis will not. If true, patients requiring laparotomy and bowel resection could be identified and patients in whom angiographic intervention led to successful cure of disease would not be exposed to potentially perilous surgery.